Genezen
The GMP Material Handler – Process Development & Manufacturing Support ensures the timely availability, accurate inventory management, and compliant handling of materials and supplies for Process Development and Manufacturing operations. This hands-on role involves coordinating supply orders, maintaining inventory, supporting cleanroom material preparation, and collaborating with cross-functional teams to ensure operational readiness. The position requires a proactive approach to safety, quality, and continuous improvement within a regulated pharmaceutical environment.
Headquarters
Lexington, Massachusetts, United States
Company Size
51-200 employees
Founded
2014
Genezen is a contract development and manufacturing organization (CDMO) focused on viral vector production to accelerate gene and cell therapies. It provides expertise, GMP-capable facilities, and end-to-end capabilities to support process development, scale-up and commercial manufacturing for advanced biologics. Genezen positions itself as a partner to biotech and pharma teams, offering quality systems, analytical support, and manufacturing capacity to shorten timelines and reduce development risk.
Genezen and Atsena Therapeutics Announce Strategic Commercial Manufacturing Partnership
1 month ago
Genezen Announces Manufacturing Partnership with Humane Genomics to Advance Oncolytic Virus Therapy for Pediatric Liver Cancer
Nov 12, 2025
Pharmaceutical company planning to relocate from California to Fishers
Jun 17, 2025
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Genezen.
Genezen didn’t post a salary, so this is our estimate from similar listings.
UniQure sells gene therapy manufacturing site to Genezen, along with production of CSL's Hemgenix
Jul 1, 2024